.webp)
The All-on-4 dental implant protocol carries one of the most consistently published long-term success rates in restorative dentistry: 95–98% implant survival at 10 years across multiple independent centres and patient populations. This is not a marketing figure — it is the cumulative result of data from thousands of patients treated by experienced surgeons following the protocol correctly. Understanding what drives that outcome — and what undermines it — is more clinically useful than the number alone.
The All-on-4 Protocol: What Makes It Work
All-on-4 places four implants per arch: two anterior implants in the vertical position, two posterior implants angled at 30–45 degrees. The angulation places the posterior implant apex in the denser bone anterior to the maxillary sinus — avoiding the sinus entirely in most cases and eliminating the need for sinus augmentation that conventional full-arch implant placement would require. AP spread (the anterior-posterior distance between the most anterior and most posterior implants) is typically 20–25mm, which is sufficient to support a full-arch bridge without cantilever length exceeding 10–15mm.
Immediate loading is the standard protocol: a provisional bridge is placed on the day of surgery, and the patient leaves with functional teeth. The final monolithic zirconia bridge is delivered at 3–6 months after osseointegration is confirmed by ISQ measurement.
What the 95–98% Survival Rate Means
The 95–98% figure refers to implant fixture survival at 10 years. This means: of all implants placed in All-on-4 full-arch cases by experienced surgeons with appropriate patient selection, approximately 95–98 out of 100 implants are still functional in the jawbone at the 10-year review. The 2–5% that fail typically do so in the first 8–16 weeks during osseointegration (primary failure), rather than after years of function (late failure). The prosthesis (the bridge) has a separate lifespan: acrylic-on-metal 8–12 years, monolithic zirconia 15–20 years. Bridge replacement does not mean implant replacement — the implants are retained and a new bridge is fabricated.
What Determines Long-Term Outcomes
Bone density and quality: Misch Type I–II mandibular bone and anterior maxillary bone achieve high primary stability reliably. Soft Type III–IV bone requires active thread systems (Nobel Active, MegaGen AnyRidge) to reach the 35 Ncm insertion torque threshold for immediate loading. CBCT assessment before surgery determines which system is required for each site.
Surgical precision: Implant angulation, depth, and AP spread are planned from the CBCT virtual plan and executed with a 3D-printed surgical guide at Dazzle (under 1mm apex deviation, under 2° angular deviation). Freehand full-arch placement without guided surgery produces higher positional variance and less predictable prosthetic outcomes.
Medical history: Uncontrolled diabetes (impairs vascular healing), active smoking (2–3× higher peri-implantitis risk), and bone-metabolic medications affect osseointegration. These are assessed at medical history review before surgery is planned. Patients are counselled on smoking cessation before treatment begins.
Peri-implant hygiene maintenance: Peri-implantitis — bacterial biofilm-driven inflammation around the implant neck — is the leading cause of late implant failure. It is preventable. The protocol: daily water flosser under the bridge, biannual professional cleaning with titanium-safe instruments, annual radiographs for the first two years to track marginal bone levels. Patients who follow this maintenance protocol are overwhelmingly represented in the long-term success data. See our detailed maintenance guide for the full protocol.
Nightguard for bruxists: Parafunctional grinding generates forces that exceed normal occlusal load by orders of magnitude. Without a nightguard, bruxism accelerates prosthetic wear and promotes marginal bone loss at implant necks. Custom nightguard fabrication is included in the treatment plan for confirmed bruxists at Dazzle.
All-on-4 vs All-on-6: When Six Is Better
All-on-6 adds two implants per arch, reducing the distal cantilever length and distributing load across more anchor points. All-on-6 is preferable when bone volume permits the additional implants, when the patient has heavy bite forces, or when the All-on-4 AP spread would produce a cantilever longer than 12–15mm. At Dazzle, the choice is determined by the CBCT assessment, not a default preference. Premium All-on-6: ₹4–5L per arch. MIRA All-on-4: ₹2L per arch.
International Patients
All-on-4 at Dazzle costs 50–70% less than equivalent treatment in the UK, Australia, and GCC. Nobel Biocare, Straumann, and MegaGen systems are used — the same brands available in those markets. The two-visit structure (Visit 1: surgery and provisional; Visit 2 at 3–6 months: final zirconia bridge) accommodates international travel schedules. Remote CBCT review before travel is available.
FAQs
Q1: What is the typical lifespan of All-on-4 implants?
The implant fixtures: 20+ years with good hygiene maintenance. The prosthesis: acrylic-on-metal 8–12 years, monolithic zirconia 15–20 years. Bridge replacement does not involve repeat surgery; a new bridge is fabricated and attached to the existing integrated implants.
Q2: Can I get All-on-4 if I’ve been told I have insufficient bone?
The angled posterior implants in All-on-4 were specifically designed to work in reduced posterior maxillary bone, often avoiding sinus augmentation entirely. A CBCT assessment determines what is possible for your specific anatomy. Patients with very severe bone loss may require zygomatic or pterygoid implants as an alternative or adjunct.
Q3: Is the surgery painful?
Performed under local anaesthesia with conscious sedation. No pain during surgery. Post-operative discomfort peaks at 48–72 hours (swelling, manageable soreness) and resolves over 5–7 days with prescribed analgesia. Most patients describe the experience as less difficult than they anticipated.
Q4: How do I know if my All-on-4 implants are integrating correctly?
ISQ measurement (resonance frequency analysis) at the 3-month appointment confirms osseointegration. Periapical radiographs at 6 months and 12 months track marginal bone levels. At Dazzle, these follow-up checkpoints are part of the treatment protocol, not optional.
